Compounds > tyrosine

tyrosine and Stroke

tyrosine has been researched along with Stroke in 72 studies

Research

Studies (72)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's28 (38.89)29.6817
2010's38 (52.78)24.3611
2020's6 (8.33)2.80

Authors

AuthorsStudies
Huang, W; Lei, B; Li, F; Li, H; Liu, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Yang, Q; Zhang, M; Zhou, P; Zhou, Z; Zi, W1
Fei, G; Li, Q; Lin, L; Qi, B; Xu, B; Zhang, Y1
Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, S; Luo, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Song, J; Tian, Y; Yang, J; Yang, Q; Zi, W1
Altmann, S; Brockmann, C; Brockmann, MA; Dillinger, D; Kerz, T; Maus, V; Mpotsaris, A; Othman, AE; Ringel, F; Spreer, A; Waldeck, S1
Afonso, C; Bonino, L; Borthagaray, G; López, E; Medeiros, R; Pitt, A; Rossi, S; Sousa, B; Spickett, C1
Akhtari, S; Chandran, V; Colaco, K; Cook, RJ; Eder, L; Gladman, DD; Harvey, P; Lee, KA; McInnes, IB; Piguet, V; Sattar, N; Welsh, P; Winer, R1
Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F1
Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W1
Feng, W; Huang, SH; Li, W; Li, XS; Liang, CR; Lin, L; Liu, CC; Wang, H; Wang, YJ; Wu, Y; Xu, ZQ; Zhang, LL; Zhang, M1
Nash, KM; Schiefer, IT; Shah, ZA1
Gao, D; Hu, S; Li, H; Li, M; Wang, H; Zhang, H; Zhu, J1
Arumugam, TV; Broughton, BR; Chu, HX; Drummond, GR; Evans, MA; Gelderblom, M; Huber, S; Kim, HA; Lee, S; Magnus, T; Piepke, M; Sakkal, S; Shim, R; Sobey, CG; Vinh, A; Wong, CH; Zhang, SR1
Bendszus, M; Hacke, W; Hametner, C; Kellert, L; Ringleb, P; Rohde, S; Stampfl, S1
Bogdahn, U; Schlachetzki, F; Schuierer, G1
Hametner, C; Kellert, L; Stampfl, S1
Aass, HC; Amthor, KF; Ormstad, H; Sandvik, L; Verkerk, R1
Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I1
Baik, SK; Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Park, SP1
Chen, JH; Kuo, HC; Lee, KF; Tsai, TH1
Du, CP; Hou, XY; Kong, FS; Li, T; Liu, Y; Sun, CC; Wang, Y; Xu, H; Zhu, QJ1
Alameda, F; Bosch-Morató, M; Caballo, C; Escolar, G; Galan, AM; Gil-Gómez, G; Guivernau, B; Guix, FX; Ill-Raga, G; Jiménez-Conde, J; Lopez-Vilchez, I; Muñoz, FJ; Ois, A; Opazo, C; Palomer, E; Pérez-Asensio, F; Planas, AM; Ramos-Fernández, E; Reyes-Navarro, M; Roquer, J; Tajes, M; Valls-Comamala, V; Valverde, MA1
Abdelsaid, M; Coucha, M; Ergul, A; Fagan, SC; Hafez, S; Johnson, MH; Li, W; Prakash, R1
Ganti, L1
Bijak, M; Cichoń, N; Miller, E; Niwald, M; Saluk, J1
Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL1
Chu, IK; Law, HC; Quan, Q; Szeto, SS; Wang, Y; Zhang, Z1
Ormstad, H; Sandvik, L; Verkerk, R1
Chen, SL; Chen, YD; Chen, YG; Cheng, XS; Ge, JB; Han, YL; Jiang, TM; Li, JL; Li, Y; Liang, ZY; Liu, HW; Liu, ML; Ma, LK; Ma, YT; Wang, G; Wang, HY; Xie, Q; Yang, BS; Zhao, X; Zheng, XQ1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD1
Zhang, W; Zhang, XA1
Dempsey, RJ; Kaimal, B; Kim, T; Lyons, K; Mehta, SL; Vemuganti, R1
Chen, J; Feng, W; Huang, S; Li, W; Li, X; Liang, C; Lin, L; Liu, C; Wang, Y; Wu, Y; Zhang, M1
Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G1
Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E1
Bosnyak, E; Koller, A; Komoly, S; Marko, L; Nagy, J; Pusch, G; Szapary, L; Toth, P; Wittmann, I1
Cao, W; Glushakov, A; Martynyuk, AE; Mecca, AP; Seubert, CN; Shah, HP; Shi, P; Sumners, C1
Oberstrass, H; Ringelstein, A; Seitz, RJ; Siebler, M; Wittsack, HJ1
Chern, CM; Liao, JF; Liou, KT; Shen, YC; Wang, YH; Yen, JC1
Baik, SK; Hwang, JC; Kwon, JH; Shin, SH; Weon, YC1
Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW1
Brait, VH; De Silva, TM; Drummond, GR; Miller, AA; Sobey, CG1
Baik, SK; Lee, JH; Oh, SJ; Park, KP1
Hamada, J; Hori, O; Kamide, T; Kawano, T; Kitao, Y; Mohri, H; Munesue, S; Okada, A; Schmidt, AM; Takeichi, T; Yamamoto, H; Yamamoto, Y1
Chen, X; Ren, C; Wei, D; Zhao, H1
Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH1
Bassand, JP1
Ikeda, M; Ito, T; Suzuki, M; Tabuchi, M; Tomita, I; Tomita, T; Umegaki, K1
Hamzavi, M; Junghans, U; Ringleb, PA; Schranz, C; Seitz, RJ; Siebler, M1
Haerten, K; Krabbe, C; Raiber, M1
Dennis, DM; Glushakov, AV; Kagiyama, T; Martynyuk, AE; Ozcan, MS; Phillips, MI; Roose, B; Seubert, CN; Sumners, C1
Aquilani, R; Arcidiaco, P; Arrigoni, N; Boschi, F; Dossena, M; Iadarola, P; Pastoris, O; Scocchi, M; Sessarego, P; Verri, M1
Albuquerque, FC; Deshmukh, VR; Fiorella, DJ; Flaster, M; Frey, J; McDougall, CG; Spetzler, RF; Wallace, RC1
Ikeda, K; Xu, JW; Yamori, Y1
Coull, BM; McDonagh, PF; Ritter, LS; Stempel, KM1
Dambrink, JH; de Boer, MJ; De Luca, G; Ernst, N; Gosslink, AT; Hoorntje, JC; Ottervanger, JP; Smit, JJ; Suryapranata, H; van 't Hof, AW1
Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y1
Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P1
Chaki, S; Craft, TK; DeVries, AC; Khanna, S; Notestine, MA; Parinandi, NL; Rink, C; Roy, S; Sen, CK; Slivka, A1
Bukow, SC; Daffertshofer, M; Hennerici, MG1
Elango, C; Jatana, M; Khan, M; Paintlia, AS; Singh, AK; Singh, I1
Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD1
Amaro, S; Chamorro, A; Planas, AM; Romanos, E1
Del Pace, S; Scheggi, V1
Amiri, F; Brassard, P; Iglarz, M; Javeshghani, DM; Pu, Q; Schiffrin, EL; Webb, RL1
Kent, TA; Mandava, P; Thiagarajan, P1
Ben-Ari, Y; Benjelloun, N; Charriaut-Marlangue, C; Ducrocq, S; Plotkine, M1
Montalescot, G1
Barone, FC; Christopher, TA; Gao, F; Lopez, BL; Ma, XL; Nelson, AH; Yue, TL1
Aulich, A; Freund, HJ; Junghans, U; Seitz, RJ; Siebler, M1
Giffard, RG; Han, HS; Karabiyikoglu, M; Qiao, Y; Yenari, MA1
Iwao, H; Kawano, H; Kim, S; Zhan, Y1
Cucchiara, BL; Hurst, RW; Liebeskind, DS; McGarvey, ML; Pollard, JR; Schwartz, ED1

Reviews

4 review(s) available for tyrosine and Stroke

ArticleYear
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2014, Mar-08, Issue:3

    Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine

2014
Tirofiban for the treatment of ischaemic stroke.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:1

    Topics: Animals; Brain Ischemia; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine

2006
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.
    Drugs, 2008, Volume: 68, Issue:8

    Topics: Abciximab; Acute Disease; Animals; Antibodies, Monoclonal; Brain Ischemia; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine

2008
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
    Clinical cardiology, 2000, Volume: 23 Suppl 6

    Topics: Arteriosclerosis; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tirofiban; Tyrosine

2000

Trials

8 trial(s) available for tyrosine and Stroke

ArticleYear
Endovascular treatment with versus without tirofiban for stroke patients with large vessel occlusion: The multicenter, randomized, placebo-controlled, double-blind RESCUE BT study protocol.
    International journal of stroke : official journal of the International Stroke Society, 2022, Volume: 17, Issue:10

    Topics: Arterial Occlusive Diseases; Double-Blind Method; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2022
RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.
    International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:5

    Topics: Aspirin; Double-Blind Method; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2023
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    American heart journal, 2016, Volume: 177

    Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine

2016
Treatment of progressive stroke with tirofiban--experience in 35 patients.
    Cerebrovascular diseases (Basel, Switzerland), 2009, Volume: 28, Issue:5

    Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2009
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Cerebrovascular diseases (Basel, Switzerland), 2010, Volume: 29, Issue:3

    Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2010
Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
    Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 31, Issue:6

    Topics: Aged; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recovery of Function; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Tyrosine

2011
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Stroke, 2011, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine

2011
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
    Cerebrovascular diseases (Basel, Switzerland), 2001, Volume: 12, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2001

Other Studies

60 other study(ies) available for tyrosine and Stroke

ArticleYear
Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery.
    Applied biochemistry and biotechnology, 2022, Volume: 194, Issue:11

    Topics: Argininosuccinic Acid; Biomarkers; Glucosamine; Glycerophospholipids; Humans; Ischemic Stroke; Lysine; Metabolomics; Oxygen; Phenylalanine; RNA, Transfer; Stroke; Tryptophan; Tyrosine

2022
Safety Profile and Complication Rates in Emergency Off-label Use of Tirofiban in Interventional Neuroradiology : An Observational Dual Center Study.
    Clinical neuroradiology, 2023, Volume: 33, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Fibrinolytic Agents; Humans; Ischemic Stroke; Middle Aged; Off-Label Use; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2023
Identification and relative quantification of 3-nitrotyrosine residues in fibrinogen nitrated in vitro and fibrinogen from ischemic stroke patient plasma using LC-MS/MS.
    Free radical biology & medicine, 2021, Volume: 165

    Topics: Brain Ischemia; Chromatography, Liquid; Fibrinogen; Hemostatics; Humans; Ischemic Stroke; Nitrates; Stroke; Tandem Mass Spectrometry; Tyrosine

2021
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:11

    Topics: Adult; Alanine; Angina Pectoris; Apolipoproteins B; Arthritis, Psoriatic; Cardiovascular Diseases; Cholesterol; Fatty Acids, Unsaturated; Female; Heart Failure; Humans; Ischemic Attack, Transient; Lipoproteins, HDL; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Psoriasis; Risk Assessment; Stroke; Tyrosine

2021
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
    World neurosurgery, 2017, Volume: 103

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial

2017
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
    Stroke, 2017, Volume: 48, Issue:12

    Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine

2017
Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
    Journal of the neurological sciences, 2017, Dec-15, Volume: 383

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Proof of Concept Study; Stroke; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine

2017
Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke.
    Free radical biology & medicine, 2018, 02-01, Volume: 115

    Topics: Animals; Antioxidants; Caspase 3; Cell Survival; Cells, Cultured; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Microglia; Neurons; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Stroke; Tyrosine

2018
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Medicine, 2018, Volume: 97, Issue:21

    Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon, Coronary; Catheters; Drug Administration Routes; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2018
IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.
    JCI insight, 2018, 09-20, Volume: 3, Issue:18

    Topics: Animals; Brain Injuries; Brain Ischemia; Cytokines; Disease Models, Animal; Inflammation; Interleukin-10; Interleukin-33; Interleukin-4; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Stroke; Th1 Cells; Th2 Cells; Treatment Outcome; Tyrosine

2018
Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome.
    Stroke, 2013, Volume: 44, Issue:5

    Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk; Stroke; Thrombectomy; Tirofiban; Tyrosine

2013
Letter by Schlachetzki et al regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
    Stroke, 2013, Volume: 44, Issue:9

    Topics: Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tyrosine

2013
Response to letter regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
    Stroke, 2013, Volume: 44, Issue:9

    Topics: Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tyrosine

2013
Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.
    Journal of molecular neuroscience : MN, 2013, Volume: 51, Issue:3

    Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Catecholamines; Cytokines; Female; Glucose; Humans; Inflammation; Male; Middle Aged; Stroke; Tryptophan; Tyrosine

2013
Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban.
    Cerebrovascular diseases (Basel, Switzerland), 2014, Volume: 37, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine

2014
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine.
    Toxicology and applied pharmacology, 2014, Sep-15, Volume: 279, Issue:3

    Topics: Animals; Biphenyl Compounds; Blotting, Western; Brain; Brain Ischemia; Cell Death; Endoplasmic Reticulum Stress; Immunohistochemistry; Indicators and Reagents; Ischemic Attack, Transient; Lignans; Male; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stroke; Transcription Factor CHOP; Tyrosine

2014
Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemia.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-23, Volume: 111, Issue:38

    Topics: Animals; Brain Ischemia; GluK2 Kainate Receptor; HEK293 Cells; Hippocampus; Humans; Male; Mitogen-Activated Protein Kinase 10; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Signal Transduction; src-Family Kinases; Stroke; Tyrosine; Up-Regulation

2014
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
    Biochimica et biophysica acta, 2015, Volume: 1852, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Brain; Brain Ischemia; Caspase 3; Cell Line, Tumor; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neurons; Rats; Rats, Sprague-Dawley; Stroke; Tyrosine

2015
Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes.
    Diabetes, 2015, Volume: 64, Issue:5

    Topics: Animals; Apoptosis; Brain; Diabetes Mellitus; Metformin; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Subunits; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stress, Physiological; Stroke; Tyrosine

2015
Do Glycoprotein IIb/IIIa Inhibitors Improve Outcomes in Acute Ischemic Stroke?
    Annals of emergency medicine, 2015, Volume: 66, Issue:1

    Topics: Antibodies, Monoclonal; Aspirin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tyrosine

2015
Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke.
    Oxidative medicine and cellular longevity, 2015, Volume: 2015

    Topics: Aged; Aged, 80 and over; Blood Proteins; Catalase; Depression; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Humans; Male; Middle Aged; Oxidative Stress; Spectrophotometry; Stroke; Sulfhydryl Compounds; Tyrosine

2015
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor

2015
Fully automated multidimensional reversed-phase liquid chromatography with tandem anion/cation exchange columns for simultaneous global endogenous tyrosine nitration detection, integral membrane protein characterization, and quantitative proteomics mappin
    Analytical chemistry, 2015, Oct-06, Volume: 87, Issue:19

    Topics: Animals; Brain; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Equipment Design; Macaca fascicularis; Male; Membrane Proteins; Nitro Compounds; Proteomics; Stroke; Tyrosine

2015
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?
    Journal of molecular neuroscience : MN, 2016, Volume: 58, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Middle Aged; Phenylalanine; Stroke; Tyrosine

2016
[A large-scale, multicenter, retrospective study on efficacy of bivalirudin use during peri-percutaneous coronary intervention period for Chinese patients with coronary heart disease].
    Zhonghua xin xue guan bing za zhi, 2016, Volume: 44, Issue:2

    Topics: Aged; China; Coronary Disease; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Retrospective Studies; Stroke; Tirofiban; Tyrosine

2016
A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
    Cell biochemistry and biophysics, 2015, Volume: 72, Issue:3

    Topics: Aged; Biomarkers; Caproates; Case-Control Studies; Depression; Dicarboxylic Acids; Female; Glyceric Acids; Humans; Hydroxy Acids; Male; Metabolome; Middle Aged; Phenylalanine; Pseudouridine; Stroke; Tyrosine

2015
Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 06-29, Volume: 36, Issue:26

    Topics: alpha-Synuclein; Animals; Brain Infarction; Brain Ischemia; Caspase 3; Death-Associated Protein Kinases; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Motor Activity; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; RNA, Small Interfering; Stroke; Tyrosine

2016
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
    Stroke, 2016, Volume: 47, Issue:10

    Topics: Aged; Brain; Brain Ischemia; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2016
Microalbuminuria, indicated by total versus immunoreactive urinary albumins, in acute ischemic stroke patients.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2011, Volume: 20, Issue:6

    Topics: Aged; Albuminuria; Biomarkers; Brain Ischemia; Chi-Square Distribution; Chromatography, High Pressure Liquid; Creatinine; Humans; Hungary; Immunoassay; Linear Models; Nephelometry and Turbidimetry; Predictive Value of Tests; Prevalence; Prognosis; Severity of Illness Index; Stroke; Tyrosine

2011
Halogenated aromatic amino acid 3,5-dibromo-D: -tyrosine produces beneficial effects in experimental stroke and seizures.
    Amino acids, 2011, Volume: 40, Issue:4

    Topics: Animals; Blood Pressure; Brain; Caspase 3; Disease Models, Animal; Endothelin-1; Epilepsy; Heart Rate; Hydrocarbons, Brominated; Infarction, Middle Cerebral Artery; Male; Motor Activity; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stroke; Tyrosine

2011
Andrographolide inhibits PI3K/AKT-dependent NOX2 and iNOS expression protecting mice against hypoxia/ischemia-induced oxidative brain injury.
    Planta medica, 2011, Volume: 77, Issue:15

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cerebral Infarction; Disease Models, Animal; Diterpenes; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Male; Mice; Mice, Inbred ICR; Microglia; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Nitrosation; Phosphatidylinositol 3-Kinase; Reactive Oxygen Species; Stroke; Superoxides; Tyrosine; Up-Regulation

2011
Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Neuroradiology, 2011, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2011
Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Animals; Cerebral Arteries; Cerebrovascular Circulation; Crosses, Genetic; Ischemia; Leukocyte Common Antigens; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Middle Cerebral Artery; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Reperfusion Injury; Stroke; Superoxides; Tyrosine

2011
Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke.
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2011, Volume: 17, Issue:4

    Topics: Acute Disease; Adult; Blood Flow Velocity; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2011
RAGE mediates vascular injury and inflammation after global cerebral ischemia.
    Neurochemistry international, 2012, Volume: 60, Issue:3

    Topics: Animals; Brain Ischemia; Carotid Artery Injuries; Cell Death; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neuroglia; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Stroke; Tumor Necrosis Factor-alpha; Tyrosine; Vascular System Injuries

2012
The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Animals; Extremities; Galectins; Inflammation; Ischemic Preconditioning; Nitric Oxide Synthase Type II; Rats; Receptors, Cell Surface; Stroke; Time Factors; Tyrosine

2012
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2012
[Platelet antiaggregation treatment in the aftermath of GUSTO IV, TARGET, TACTICS, and CURE trials].
    Revista espanola de cardiologia, 2002, Volume: 55, Issue:7

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Time Factors; Tirofiban; Tyrosine

2002
Fluctuation of serum NO(x) concentration at stroke onset in a rat spontaneous stroke model (M-SHRSP). Peroxynitrite formation in brain lesions.
    Brain research, 2002, Sep-13, Volume: 949, Issue:1-2

    Topics: Animals; Brain; Immunohistochemistry; Magnetic Resonance Imaging; Male; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tyrosine

2002
Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
    Stroke, 2003, Volume: 34, Issue:8

    Topics: Acute Disease; Aged; Case-Control Studies; Drug Therapy, Combination; Feasibility Studies; Fibrinolytic Agents; Humans; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2003
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
    Deutsche medizinische Wochenschrift (1946), 2004, Mar-19, Volume: 129, Issue:12

    Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler

2004
Neuroprotective action of halogenated derivatives of L-phenylalanine.
    Stroke, 2004, Volume: 35, Issue:5

    Topics: Animals; Disease Models, Animal; In Vitro Techniques; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Stroke; Synaptic Transmission; Tyrosine

2004
Plasma precursors of brain catecholaminergic and serotonergic neurotransmitters in rehabilitation patients with ischemic stroke.
    Archives of physical medicine and rehabilitation, 2004, Volume: 85, Issue:5

    Topics: Aged; Brain Ischemia; Case-Control Studies; Humans; Male; Nutritional Status; Stroke; Stroke Rehabilitation; Tryptophan; Tyrosine

2004
Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
    Neurosurgery, 2005, Volume: 56, Issue:1

    Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Brain Ischemia; Chemotherapy, Adjuvant; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

2005
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:9

    Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents

2004
Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
    Biological research for nursing, 2005, Volume: 6, Issue:4

    Topics: Analysis of Variance; Animals; Anticoagulants; Biomarkers; Blood Platelets; Brain Ischemia; Disease Models, Animal; Flow Cytometry; Inflammation; Leukocytes; Male; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Tirofiban; Tyrosine

2005
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:5

    Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Fibrinolytic Agents; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Stroke; Time Factors; Tirofiban; Tyrosine

2005
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:4

    Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents

2005
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
    Stroke, 2005, Volume: 36, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2005
Neuroprotective properties of the natural vitamin E alpha-tocotrienol.
    Stroke, 2005, Volume: 36, Issue:10

    Topics: Animals; Antioxidants; Arachidonate 12-Lipoxygenase; Brain; Cell Death; Cell Line; Cell Survival; Cells, Cultured; Cerebral Cortex; CSK Tyrosine-Protein Kinase; Fluoresceins; Glutamic Acid; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Organic Chemicals; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Random Allocation; Rats; Rats, Inbred SHR; src-Family Kinases; Stroke; Time Factors; Tocotrienols; Transfection; Tyrosine; Vitamin E

2005
Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.
    Nitric oxide : biology and chemistry, 2006, Volume: 15, Issue:2

    Topics: Animals; Brain Chemistry; Brain Ischemia; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Lipids; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Stroke; Structure-Activity Relationship; Tyrosine

2006
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
    Circulation, 2006, Mar-21, Volume: 113, Issue:11

    Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2006
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007, Volume: 27, Issue:1

    Topics: Animals; Brain Damage, Chronic; Brain Edema; Humans; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Neutrophil Infiltration; Nitrates; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Stroke; Thromboembolism; Tissue Plasminogen Activator; Tyrosine; Uric Acid

2007
Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0.
    Internal and emergency medicine, 2006, Volume: 1, Issue:3

    Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Brain Ischemia; Contraindications; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Patient Selection; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

2006
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Journal of hypertension, 2008, Volume: 26, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Endomyocardial Fibrosis; Endothelium, Vascular; Hydralazine; Hypertension; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Tetrazoles; Tyrosine; Valine; Valsartan

2008
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
    Journal of neurochemistry, 2000, Volume: 74, Issue:6

    Topics: Animals; Animals, Newborn; Benzamides; Brain Ischemia; Cell Death; Cerebral Infarction; Encephalitis; Female; Male; Motor Activity; Neurologic Examination; Neuroprotective Agents; Neutrophils; Nitrates; Poly(ADP-ribose) Polymerase Inhibitors; Polymers; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stroke; Time Factors; Tyrosine

2000
Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:3

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Apoptosis; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular; Immunohistochemistry; In Situ Nick-End Labeling; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Propanolamines; Rats; Rats, Inbred SHR; Stroke; Tyrosine

2001
Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10

    Topics: Animals; Cells, Cultured; Disease Models, Animal; Encephalitis; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Microglia; Monocytes; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Stroke; Tyrosine

2002
Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:2

    Topics: Albuminuria; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Genetic Predisposition to Disease; Hypertension; Kidney Glomerulus; Male; Phosphorylation; Proteinuria; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Platelet-Derived Growth Factor beta; Stroke; Tyrosine

2002
Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
    Journal of thrombosis and thrombolysis, 2002, Volume: 13, Issue:2

    Topics: Aged; Arterial Occlusive Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Vertebrobasilar Insufficiency

2002